209 related articles for article (PubMed ID: 34466084)
1. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines.
Alshetaili AS
Saudi J Biol Sci; 2021 Sep; 28(9):5065-5073. PubMed ID: 34466084
[TBL] [Abstract][Full Text] [Related]
2. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
3. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells.
Alsulays BB; Aodah AH; Ahmed MM; Anwer MK
Int J Nanomedicine; 2024; 19():3461-3473. PubMed ID: 38617799
[TBL] [Abstract][Full Text] [Related]
6. A Chitosan-PLGA based catechin hydrate nanoparticles used in targeting of lungs and cancer treatment.
Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Buheazah TM; AlHomoud HS; Al-Nasif HA; Alam MA
Saudi J Biol Sci; 2020 Sep; 27(9):2344-2357. PubMed ID: 32884416
[TBL] [Abstract][Full Text] [Related]
7. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
[TBL] [Abstract][Full Text] [Related]
8. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
10. Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment.
Al-Nemrawi NK; Altawabeyeh RM; Darweesh RS
J Pharm Sci; 2022 Feb; 111(2):485-494. PubMed ID: 34728172
[TBL] [Abstract][Full Text] [Related]
11. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.
Lee SY; Koo JS; Yang M; Cho HJ
J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
14. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
15. Polysorbate 80 surface modified PLGA nanoparticles: an
Sharma S; Dang S
J Microencapsul; 2023 Nov; 40(7):534-548. PubMed ID: 37530105
[TBL] [Abstract][Full Text] [Related]
16. Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide.
Shi Y; Xue J; Jia L; Du Q; Niu J; Zhang D
Colloids Surf B Biointerfaces; 2018 Jan; 161():67-72. PubMed ID: 29040836
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-Coated PLGA Nanoparticles Loaded with
Azzazy HME; Fahmy SA; Mahdy NK; Meselhy MR; Bakowsky U
Nanomaterials (Basel); 2021 Sep; 11(9):. PubMed ID: 34578755
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of BSA-Loaded PLGA-Chitosan Composite Nanoparticles for the Protein-Based Drug Delivery System.
Gaur M; Maurya S; Akhtar MS; Yadav AB
ACS Omega; 2023 May; 8(21):18751-18759. PubMed ID: 37273604
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
20. Coating of chitosan on poly D,L-lactic-co-glycolic acid thymoquinone nanoparticles enhances the anti-tumor activity in triple-negative breast cancer.
Gao J; Kumari A; Zeng XA; Chan S; Farooq MA; Alee M; Khan SH; Rahaman A; He S; Xin X; Mehmood T
Front Chem; 2023; 11():1044953. PubMed ID: 36846852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]